VRTX - VERTEX PHARMACEUTICALS INC / MA
477.89
3.620 0.757%
Share volume: 989,412
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$474.27
3.62
0.01%
Summary score
61%
Profitability
81%
Dept financing
7%
Liquidity
75%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.86%
Return on assets
4.06%
Return on sales
25.03%
Return on invested capital
1982.17%
Total debt ratio
36.43%
Debt ratio change over timeo
0%
Current Ratio
3.51%
Quick Ratio
3.39%
Cash Position Ratio
2.32%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
9.56%
Return on assets
6.92%
Return on sales
44.43%
Return on invested capital
35.86%
Total debt ratio
27.16%
Debt ratio change over timeo
0%
Current Ratio
3.65%
Quick Ratio
3.53%
Cash Position Ratio
2.51%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
8.21%
Return on assets
6.03%
Return on sales
44.08%
Return on invested capital
36.29%
Total debt ratio
28.03%
Debt ratio change over time
0%
Current Ratio
3.72%
Quick Ratio
3.6%
Cash Position Ratio
2.68%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VRTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 7.86% | 18.71% | 4.67% | -3.65% |
| Return on assets | 4.06% | 3.4% | 3.32% | 3.5% |
| Return on sales | 25.03% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 1982.17% | 5.38% | 4.17% | 4.99% |
| Profitability | 80% | 65% | 47% | 47% |
| Total debt ratio | 36.43% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 9% | 20% | 20% | 50% |
| Current Ratio | 3.65% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 3.53% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 2.51% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 21% | 27% | 28% |
| Short-term ratios | VRTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 9.56% | 41.05% | 6.87% | -16.17% |
| Return on assets | 6.92% | 3.67% | 3.13% | 2.71% |
| Return on sales | 44.43% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 35.86% | 9.43% | 5.58% | 6.54% |
| Profitability | 81% | 60% | 33% | 31% |
| Total debt ratio | 27.16% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 7% | 23% | 40% | 25% |
| Current Ratio | 3.65% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 3.53% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 2.51% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 17% | 23% | 41% |